Search

Depression is accompanied by dyslipidemia, which may increase the risk of stroke and coronary heart disease. This study sought to quantitatively summarize the clinical data comparing peripheral blood triglyceride (TG) concentrations between patients with major depressive disorder (MDD) and healthy controls (HCs). Studies were searched in PubMed, EMBASE, PsycINFO, and Cochrane Databases up to March 2023. We also reviewed the reference lists of obtained articles. Mean (±SD) for TG concentrations were extracted, combined quantitatively using random-effects meta-analysis, and summarized as a standardized mean difference (SMD). Subgroup analysis and meta-regression was performed to explore the resource of heterogeneity. Thirty-eight studies measuring the concentrations of peripheral blood TG in 2604 patients with MDD and 3272 HCs were included. Meta-analysis results indicated that TG levels were significant higher in patients with MDD than in HCs (SMD = 0.31, 95% confidence interval [CI]: 0.16 to 0.46, Z46 = 4.05, p < 0.01). Heterogeneity was detected (χ2 = 269.97, p < 0.01, I2 = 85%). Subgroup analysis demonstrated significant differences in TG levels between patients with MDD and HCs depended on age, body mass index and drug use (p < 0.05), but no differences between groups. Meta-regression also found no significant variables. TG level was significantly elevated in depression, which may explain the increased risk of cardiovascular and cerebrovascular events in depression. [ABSTRACT FROM AUTHOR]

The treatments for noninfectious uveitis (NIU) include topical steroids, local steroid injections, and systemic steroids or immunomodulatory agents. Over the last 20 years, there have been advancements in both conventional and alternative complementary therapies for uveitis. In this review, we will give an overview of the current conventional and alternative systemic treatments for NIU and discuss the possible risks and benefits to each. Conventional systemic therapies for NIU include corticosteroids, antimetabolites, biologics, calcineurin inhibitors, alkylating agents, janus kinase (JAK) inhibitors, and interferons. Alternative therapies include Ayurvedic medicine, berberine, glycosides, Traditional Chinese medicines, dietary changes, and vitamin supplementation. There are an expanding number of systemic treatments for NIU. Over the last 15 years, biologic agents in particular have expanded and improved treatment options for patients with NIU. [ABSTRACT FROM AUTHOR]

Fragment-based drug design of new bioactive scaffolds is a recent aspect of medicinal chemistry that provides a faster and more efficient road in drug discovery. Phenoxyethyl piperidine and morpholine derivatives have various pharmacological activities, from antitussive to anticancer properties. They are also widely used in selective estrogen receptor modulator (SERM) drugs and can be used to prevent osteoporosis in postmenopausal women. Also, other recent findings suggest that these compounds exhibit high anticholinergic and H3 inverse agonistic activities. We outlined the process of developing novel medications for Alzheimer's disease, malaria, cancer, and various other illnesses, which could entail modifying or incorporating these structures into a different biologically active framework. Pharmacokinetic assessment and organic pathways for synthesizing these scaffolds are also indicated. This review will discuss the recent pharmaceutical advances of phenoxyethyl cyclic amine derivatives in experimental, investigational, and FDA-approved drugs to draw an apparent viewpoint for future drug research and discovery. [ABSTRACT FROM AUTHOR]

Background: In today's society, suicide is major public problem and has become a global issue accounting for about 1.4% of the death worldwide. It is highly undesirable event and urgently requires development of preventive approaches. Hypothesis: Cholesterol is a core component of central nervous system essential for cell membrane stability and the correct functioning of neurotransmission. It is hypothesized that reduced serum cholesterol level may be accompanied by changes in function of serotonin receptors and transporters. Aims: The project 'Serum Lipid Profile Levels in Suicide Attempters' aimed to find out the relation of serum lipid levels in Suicide Attempters. Methodology: A Case Control Study was conducted and it was observed that the people coming with suicide attempt has significant decrease in the serum cholesterol levels when compared to those of normal healthy Individual. Results: Total serum cholesterol was lower in suicide attempters than the control group. The odds of suicide attempt was 3 times more in people with low serum cholesterol. Conclusion: Our study findings demonstrate that serum total cholesterol can be considered as an important and independent risk factor for Suicidality. [ABSTRACT FROM AUTHOR]